Cumberland Pharmaceuticals (NASDAQ:CPIX – Get Free Report) was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Cumberland Pharmaceuticals in a research report on Monday, December 29th. One research analyst has […]

Wall Street Zen cut shares of Telix Pharmaceuticals (NASDAQ:TLX – Free Report) from a hold rating to a sell rating in a research note published on Sunday. Other equities analysts have also recently issued reports about the company. Royal Bank Of Canada raised Telix Pharmaceuticals from a “hold” rating to a “moderate buy” rating in […]

Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) was upgraded by equities researchers at Wall Street Zen to a “sell” rating in a research report issued to clients and investors on Saturday. Several other research analysts have also commented on the company. HC Wainwright restated a “buy” rating and set a $80.00 price target on shares […]

Wall Street Zen lowered shares of ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) from a strong-buy rating to a buy rating in a research report released on Saturday. A number of other analysts have also recently commented on ANIP. Zacks Research cut shares of ANI Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a […]

Wall Street Zen downgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. A number of other research analysts have also weighed in on the company. Citigroup increased their price target on Agios Pharmaceuticals from $38.00 to $46.00 and gave […]

Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Sunday. A number of other research firms have also weighed in on SUPN. Weiss Ratings reaffirmed a “sell (d+)” rating on shares […]